Related Experiment Video
Updated: Jan 19, 2026

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization
Published on: June 7, 2016
Long noncoding RNA LINC00511 involves in breast cancer recurrence and radioresistance by regulating STXBP4 expression
1Department of Nuclear Medicine, Affiliated Hospital of Southwest Medical University, Luzhou, China. chenyuebio@126.com.
Objective:
The aim of this study was to explore the molecular function of long intergenic noncoding RNA 00511 (LINC00511) and its target proteins in recurrent breast cancer after breast-conserving surgery followed by radiotherapy.
Patients And Methods:
LINC00511 expression in tissues was measured by quantitative polymerase chain reaction (qPCR). The association between LINC00511 expression and the clinicopathological features of breast cancer was analyzed by Chi-square tests. The impact of LINC00511 on overall survival was evaluated by the log-rank test. MDA-MB-231/MDA-MB-436 cell lines transfected with short hairpin RNA (shRNA) were used to investigate the influence of LINC00511 silencing on tumor growth and radiosensitivity in vitro and in vivo. A series of experiments including cell apoptosis assay, cell colony formation assay, and mouse xenograft models were applied to test those transfected cell lines. MicroRNA (miRNA) targets of LINC00511 were identified by bioinformatics analysis and further validated by dual luciferase reporter assay, qPCR, and Western blot analysis.
Results:
LINC00511 expression was significantly increased in breast cancer tissues and correlated with recurrence and poor survival after breast-conserving surgery followed by radiotherapy. LINC00511 knockdown by shRNA restricted cell proliferation, promoted cell apoptosis, and enhanced radiosensitivity in vitro, and inhibited tumor growth with an increased response to radiation in vivo. In addition, elevated LINC00511 was found to increase syntaxin-binding protein 4 (STXBP4) expression through competitive binding to miR-185, while silencing LINC00511 decreased STXBP4 expression and increased radiosensitivity.
Conclusions:
LINC00511 inhibition impairs its competitive binding to miR-185, resulting in increased STXBP4 expression and improved radiation response in breast cancer. Our study results suggest that the LINC00511/miR-185/STXBP4 axis may be a promising therapeutic target for improving the prognosis of breast cancer.
Insights
Long intergenic noncoding RNA 00511 (LINC00511) is elevated in recurrent breast cancer, promoting tumor growth and reducing radiation sensitivity. Inhibiting LINC00511 enhances radiosensitivity by modulating the miR-185/STXBP4 axis, offering a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Recurrent breast cancer after breast-conserving surgery and radiotherapy poses a significant clinical challenge.
- Long noncoding RNAs (lncRNAs) are increasingly recognized for their roles in cancer progression and treatment response.
Purpose of the Study:
- To investigate the molecular function of long intergenic noncoding RNA 00511 (LINC00511) in recurrent breast cancer.
- To identify LINC00511's target proteins and its role in radiosensitivity after breast-conserving surgery and radiotherapy.
Main Methods:
- Quantitative polymerase chain reaction (qPCR) to measure LINC00511 expression.
- In vitro and in vivo experiments using short hairpin RNA (shRNA) to silence LINC00511 in breast cancer cell lines.
- Bioinformatics analysis, dual luciferase reporter assays, qPCR, and Western blot to identify and validate microRNA (miRNA) targets.
Main Results:
- LINC00511 expression was significantly higher in recurrent breast cancer tissues and correlated with poor survival.
- LINC00511 knockdown suppressed tumor cell proliferation, induced apoptosis, and enhanced radiosensitivity in vitro and in vivo.
- LINC00511 competitively binds to miR-185, upregulating syntaxin-binding protein 4 (STXBP4) expression and decreasing radiosensitivity.
Conclusions:
- The LINC00511/miR-185/STXBP4 axis plays a crucial role in breast cancer progression and response to radiotherapy.
- Inhibiting LINC00511 can improve radiosensitivity by restoring miR-185 function and reducing STXBP4 levels.
- Targeting the LINC00511/miR-185/STXBP4 pathway represents a promising therapeutic strategy for enhancing breast cancer treatment outcomes.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
Inheritance of Chromatin Structures
Non-LTR Retrotransposons
